symbol,statement_type,period_end,line_item,value
ADVENZYMES.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.284953
ADVENZYMES.NS,income,2025-03-31 00:00:00,Normalized EBITDA,2274770000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Total Unusual Items,0.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,1311150000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,365560000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,1518610000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,EBITDA,2274770000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,EBIT,1909210000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Net Interest Income,-35570000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Interest Expense,35570000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Interest Income,
ADVENZYMES.NS,income,2025-03-31 00:00:00,Normalized Income,1311150000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,1311150000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Total Expenses,4790300000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
ADVENZYMES.NS,income,2025-03-31 00:00:00,Diluted Average Shares,111872867.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Basic Average Shares,111872867.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Diluted EPS,11.72
ADVENZYMES.NS,income,2025-03-31 00:00:00,Basic EPS,11.72
ADVENZYMES.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,1311150000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,1311150000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Net Income,1311150000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Minority Interests,-28590000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,1339740000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,1339740000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Tax Provision,533900000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Pretax Income,1873640000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,330410000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Special Income Charges,0.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Other Special Charges,
ADVENZYMES.NS,income,2025-03-31 00:00:00,Write Off,
ADVENZYMES.NS,income,2025-03-31 00:00:00,Impairment Of Capital Assets,
ADVENZYMES.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-35570000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
ADVENZYMES.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,35570000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
ADVENZYMES.NS,income,2025-03-31 00:00:00,Operating Income,1578800000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Operating Expense,3271690000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Other Operating Expenses,1490710000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,365560000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Amortization,
ADVENZYMES.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,365560000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Research And Development,
ADVENZYMES.NS,income,2025-03-31 00:00:00,Selling General And Administration,
ADVENZYMES.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
ADVENZYMES.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
ADVENZYMES.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
ADVENZYMES.NS,income,2025-03-31 00:00:00,Gross Profit,4850490000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Cost Of Revenue,1518610000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Total Revenue,6369100000.0
ADVENZYMES.NS,income,2025-03-31 00:00:00,Operating Revenue,6369100000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,-40983960.260035
ADVENZYMES.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.270843
ADVENZYMES.NS,income,2024-03-31 00:00:00,Normalized EBITDA,2411230000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Total Unusual Items,-151320000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-151320000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,1333050000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,352420000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,1445790000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,EBITDA,2259910000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,EBIT,1907490000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Net Interest Income,-29280000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Interest Expense,29280000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Interest Income,133260000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Normalized Income,1443386039.739965
ADVENZYMES.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,1333050000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Total Expenses,4546510000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,79530000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Diluted Average Shares,111833054.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Basic Average Shares,111833054.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Diluted EPS,11.92
ADVENZYMES.NS,income,2024-03-31 00:00:00,Basic EPS,11.92
ADVENZYMES.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,1333050000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,1333050000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Net Income,1333050000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Minority Interests,-36460000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,1369510000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,1369510000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Tax Provision,508700000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Pretax Income,1878210000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,366640000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Special Income Charges,-151320000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Other Special Charges,154370000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Write Off,20950000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Impairment Of Capital Assets,0.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-29280000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,11930000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,29280000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,133260000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Operating Income,1692170000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Operating Expense,3100720000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Other Operating Expenses,1470460000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,352420000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Amortization,77400000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,352420000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Research And Development,8120000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Selling General And Administration,397220000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,156510000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,General And Administrative Expense,240710000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,79530000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Gross Profit,4792890000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Cost Of Revenue,1445790000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Total Revenue,6238680000.0
ADVENZYMES.NS,income,2024-03-31 00:00:00,Operating Revenue,6238680000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,-23816772.801094
ADVENZYMES.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.26015
ADVENZYMES.NS,income,2023-03-31 00:00:00,Normalized EBITDA,1869930000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Total Unusual Items,-91550000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-91550000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,1056390000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,350290000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,1427680000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,EBITDA,1778380000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,EBIT,1428090000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Net Interest Income,60050000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Interest Expense,24210000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Interest Income,94830000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Normalized Income,1124123227.198906
ADVENZYMES.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,1056390000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Total Expenses,4020860000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,62360000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Diluted Average Shares,111815999.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Basic Average Shares,111815999.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Diluted EPS,9.45
ADVENZYMES.NS,income,2023-03-31 00:00:00,Basic EPS,9.45
ADVENZYMES.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,1056390000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,1056390000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Net Income,1056390000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Minority Interests,17730000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,1038660000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,1038660000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Tax Provision,365220000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Pretax Income,1403880000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,39400000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Special Income Charges,-64310000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Other Special Charges,48130000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Write Off,9310000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Impairment Of Capital Assets,6870000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,60050000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,10570000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,24210000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,94830000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Operating Income,1382960000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Operating Expense,2593180000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Other Operating Expenses,752440000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,350290000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Amortization,73040000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,277250000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Research And Development,8090000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Selling General And Administration,379080000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,160820000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,General And Administrative Expense,218260000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,62360000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Gross Profit,3976140000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Cost Of Revenue,1427680000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Total Revenue,5403820000.0
ADVENZYMES.NS,income,2023-03-31 00:00:00,Operating Revenue,5403820000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,632669.094693
ADVENZYMES.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.276275
ADVENZYMES.NS,income,2022-03-31 00:00:00,Normalized EBITDA,2076080000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Total Unusual Items,2290000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,2290000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,1195820000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,349830000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,1194300000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,EBITDA,2078370000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,EBIT,1728540000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Net Interest Income,-25510000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Interest Expense,17960000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Interest Income,4040000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Normalized Income,1194162669.094693
ADVENZYMES.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,1195820000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Total Expenses,3603390000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,42380000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Diluted Average Shares,111869256.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Basic Average Shares,111777150.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Diluted EPS,10.68
ADVENZYMES.NS,income,2022-03-31 00:00:00,Basic EPS,10.7
ADVENZYMES.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,1195820000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,1195820000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Net Income,1195820000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Minority Interests,-42170000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,1237990000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,1237990000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Tax Provision,472590000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Pretax Income,1710580000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,45690000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Special Income Charges,2290000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Other Special Charges,-11500000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Write Off,9210000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Impairment Of Capital Assets,0.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-25510000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,11590000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,17960000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,4040000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Operating Income,1685650000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Operating Expense,2409090000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Other Operating Expenses,618980000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,349830000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Amortization,79980000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,269850000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Research And Development,6470000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Selling General And Administration,354850000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,147660000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,General And Administrative Expense,207190000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,42380000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Gross Profit,4094740000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Cost Of Revenue,1194300000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Total Revenue,5289040000.0
ADVENZYMES.NS,income,2022-03-31 00:00:00,Operating Revenue,5289040000.0
ADVENZYMES.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Total Unusual Items,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
ADVENZYMES.NS,income,2021-03-31 00:00:00,EBITDA,
ADVENZYMES.NS,income,2021-03-31 00:00:00,EBIT,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Net Interest Income,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Interest Expense,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Interest Income,5850000.0
ADVENZYMES.NS,income,2021-03-31 00:00:00,Normalized Income,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Total Expenses,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,21040000.0
ADVENZYMES.NS,income,2021-03-31 00:00:00,Diluted Average Shares,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Basic Average Shares,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Diluted EPS,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Basic EPS,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Net Income,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Minority Interests,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Tax Provision,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Pretax Income,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Special Income Charges,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Other Special Charges,-7250000.0
ADVENZYMES.NS,income,2021-03-31 00:00:00,Write Off,9300000.0
ADVENZYMES.NS,income,2021-03-31 00:00:00,Impairment Of Capital Assets,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,9610000.0
ADVENZYMES.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,5850000.0
ADVENZYMES.NS,income,2021-03-31 00:00:00,Operating Income,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Operating Expense,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Amortization,64120000.0
ADVENZYMES.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Research And Development,6290000.0
ADVENZYMES.NS,income,2021-03-31 00:00:00,Selling General And Administration,243780000.0
ADVENZYMES.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,85500000.0
ADVENZYMES.NS,income,2021-03-31 00:00:00,General And Administrative Expense,158280000.0
ADVENZYMES.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,21040000.0
ADVENZYMES.NS,income,2021-03-31 00:00:00,Gross Profit,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Total Revenue,
ADVENZYMES.NS,income,2021-03-31 00:00:00,Operating Revenue,
